Conformationally Restricted Hybrid Analogues of the Hormone 1α,25-Dihydroxyvitamin D3: Design, Synthesis, and Biological Evaluation

This publication has 15 references indexed in Scilit:

• EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells
  The Journal of Steroid Biochemistry and Molecular Biology, 1993
• 10th Symposium on Advances in Skin Pharmacology—CIRD GALDERMA. “From Molecular Biology to Therapeutics,” Sophia Antipolis, October 1st to 3rd, 1992
  Journal of Investigative Dermatology, 1993
• An evaluation of 1,25-dihydroxyvitamin D3 analogues on the proliferation and differentiation of cultured human keratinocytes, calcium metabolism and the differentiation of human HL-60 cells
  The Journal of Nutritional Biochemistry, 1993
• New vitamin D3 derivatives with unexpected antiproliferative activity: 1-(hydroxymethyl)-25-hydroxyvitamin D3 homologs
  Journal of Medicinal Chemistry, 1992
• A Novel Vitamin D₃Analog, 22-Oxa-1, 25- Dihydroxyvitamin D₃, Inhibits the Growth of Human Breast Cancerin Vitroandin Vivowithout Causing Hypercalcemia*
  Endocrinology, 1991
• Studies of vitamin D (calciferol) and its analogs. 39. Arocalciferols: synthesis and biological evaluation of aromatic side-chain analogs of 1.alpha.,25-dihydroxyvitamin D3
  Journal of Medicinal Chemistry, 1991
• Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during long-term treatment with the vitamin D3 analogue MC903: modulations and interrelations
  British Journal of Dermatology, 1991
• POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATION
  The Lancet, 1989
• Induction of Calcitonin Receptors by lα, 25- Dihydroxyvitamin D₃in Osteoclast-Like Multinucleated Cells Formed from Mouse Bone Marrow Cells*
  Endocrinology, 1988
• Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.
  Proceedings of the National Academy of Sciences, 1981